Khiron Life Sciences Corp
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and s… Read more
Khiron Life Sciences Corp (KHRNF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2022: -0.186x
Based on the latest financial reports, Khiron Life Sciences Corp (KHRNF) has a cash flow conversion efficiency ratio of -0.186x as of September 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.04 Million) by net assets ($27.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Khiron Life Sciences Corp - Cash Flow Conversion Efficiency Trend (2011–2021)
This chart illustrates how Khiron Life Sciences Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Khiron Life Sciences Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Khiron Life Sciences Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Notoria
WAR:NTS
|
0.085x |
|
EUTELSAT COMM.
MU:E3B
|
N/A |
|
Fonix Mobile plc
LSE:FNX
|
0.339x |
|
Liontrust Asset Management
LSE:LIO
|
0.056x |
|
Eckoh Plc
LSE:ECK
|
0.061x |
|
Pressure Biosciences Inc
OTCQB:PBIO
|
0.019x |
|
BHB BRAUHOLDING
MU:B9B
|
N/A |
|
Gamer Pakistan Inc. Common Stock
PINK:GPAK
|
-0.354x |
Annual Cash Flow Conversion Efficiency for Khiron Life Sciences Corp (2011–2021)
The table below shows the annual cash flow conversion efficiency of Khiron Life Sciences Corp from 2011 to 2021.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2021-12-31 | $33.33 Million | $-20.40 Million | -0.612x | -57.76% |
| 2020-12-31 | $63.23 Million | $-24.53 Million | -0.388x | +9.64% |
| 2019-12-31 | $70.04 Million | $-30.07 Million | -0.429x | +25.78% |
| 2018-12-31 | $25.54 Million | $-14.77 Million | -0.579x | -266.30% |
| 2017-12-31 | $134.90K | $-21.30K | -0.158x | -180.00% |
| 2016-12-31 | $-107.91K | $-21.30K | 0.197x | -67.15% |
| 2015-12-31 | $-96.86K | $-58.22K | 0.601x | +103.10% |
| 2014-12-31 | $4.97K | $-96.45K | -19.406x | -283.28% |
| 2013-12-31 | $27.68K | $-140.15K | -5.063x | -606.21% |
| 2012-12-31 | $178.64K | $-128.08K | -0.717x | -7141.91% |
| 2011-12-31 | $283.93K | $-2.81K | -0.010x | -- |